Try Fund Library Premium
For Free with a 30 day trial!
Global Equity Balanced
Click for more information on Fundata’s FundGrade.
|
NAVPS (12-12-2025) |
$14.00 |
|---|---|
| Change |
-$0.07
(-0.48%)
|
As at November 30, 2025
As at October 31, 2025
Inception Return (May 05, 2017): 7.17%
| Row Heading | Return | Annualized Return | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 Mth | 3 Mth | 6 Mth | YTD | 1 Yr | 2 Yr | 3 Yr | 4 Yr | 5 Yr | 6 Yr | 7 Yr | 8 Yr | 9 Yr | 10 Yr | |
| Fund | 0.70% | 4.48% | 10.20% | 12.21% | 10.83% | 15.35% | 11.88% | 6.87% | 7.89% | 8.14% | 8.68% | 7.24% | - | - |
| Benchmark | -0.22% | 6.14% | 13.50% | 14.42% | 14.60% | 19.27% | 15.97% | 9.42% | 9.85% | 10.05% | 10.39% | 9.26% | 9.91% | 9.39% |
| Category Average | 0.49% | 4.94% | 10.38% | 12.25% | 11.04% | 15.62% | 12.12% | 7.01% | 7.99% | 7.75% | 8.07% | 6.73% | 7.19% | 6.82% |
| Category Rank | 470 / 1,273 | 966 / 1,268 | 876 / 1,261 | 780 / 1,249 | 788 / 1,249 | 784 / 1,218 | 720 / 1,139 | 672 / 1,085 | 594 / 991 | 467 / 945 | 382 / 848 | 362 / 773 | - | - |
| Quartile Ranking | 2 | 4 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 2 | 2 | 2 | - | - |
| Return % | Dec | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fund | -1.23% | 3.01% | -0.35% | -1.56% | -2.70% | 3.57% | 2.50% | 0.94% | 1.94% | 2.97% | 0.76% | 0.70% |
| Benchmark | 0.16% | 3.26% | -0.48% | -3.00% | -2.54% | 3.76% | 3.03% | 2.10% | 1.67% | 4.09% | 2.18% | -0.22% |
6.89% (April 2020)
-8.87% (March 2020)
| Return % | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Fund | - | - | - | -5.32% | 17.17% | 11.06% | 11.85% | -11.67% | 11.62% | 15.39% |
| Benchmark | 17.03% | 3.66% | 11.99% | 0.72% | 16.29% | 12.17% | 11.33% | -12.03% | 15.07% | 21.57% |
| Category Average | 4.87% | 4.92% | 9.31% | -5.49% | 15.12% | 8.09% | 12.42% | -11.85% | 11.42% | 15.99% |
| Quartile Ranking | - | - | - | 3 | 1 | 2 | 3 | 3 | 2 | 3 |
| Category Rank | - | - | - | 481/ 778 | 195/ 861 | 252/ 946 | 603/ 994 | 588/ 1,091 | 502/ 1,139 | 840/ 1,222 |
17.17% (2019)
-11.67% (2022)
| Name | Percent |
|---|---|
| International Equity | 29.21 |
| US Equity | 24.30 |
| Canadian Equity | 18.81 |
| Foreign Corporate Bonds | 7.86 |
| Canadian Corporate Bonds | 6.82 |
| Other | 13.00 |
| Name | Percent |
|---|---|
| Fixed Income | 25.43 |
| Technology | 14.68 |
| Financial Services | 14.14 |
| Energy | 5.52 |
| Consumer Services | 5.11 |
| Other | 35.12 |
| Name | Percent |
|---|---|
| North America | 64.72 |
| Europe | 14.74 |
| Asia | 13.40 |
| Multi-National | 4.07 |
| Latin America | 2.50 |
| Other | 0.57 |
| Name | Percent |
|---|---|
| Manulife Bond Fund Advisor Series | 6.73 |
| Manulife U.S. All Cap Equity Fund Advisor Ser | 6.29 |
| Manulife Multifactor Cdn Large Cap Indx ETF (MCLC) | 6.15 |
| Manulife Global Dividend Fund Advisor Series | 6.05 |
| Manulife Fundamental Equity Fund Advisor Series | 6.04 |
| Manulife World Investment Fund Advisor Series | 5.78 |
| Manulife Dividend Income Fund Advisor Series | 5.33 |
| Manulife Growth Opportunities Fund Advisor Series | 4.97 |
| Manulife Multifactor US Lg Cap Ix ETF Uhg (MULC.B) | 4.65 |
| Manulife Global Small Cap Fund Advisor Series | 4.47 |
Manulife Growth Portfolio Series ZE (SL Eclipse)
Median
Other - Global Equity Balanced
| Standard Deviation | 7.96% | 9.08% | - |
|---|---|---|---|
| Beta | 0.95% | 0.94% | - |
| Alpha | -0.03% | -0.01% | - |
| Rsquared | 0.91% | 0.93% | - |
| Sharpe | 0.96% | 0.59% | - |
| Sortino | 2.01% | 0.85% | - |
| Treynor | 0.08% | 0.06% | - |
| Tax Efficiency | 91.89% | 86.55% | - |
| Volatility |
|
|
- |
| Key Ratio | 1 Yr | 3 Yr | 5 Yr | 10 Yr |
|---|---|---|---|---|
| Standard Deviation | 6.98% | 7.96% | 9.08% | - |
| Beta | 0.79% | 0.95% | 0.94% | - |
| Alpha | 0.00% | -0.03% | -0.01% | - |
| Rsquared | 0.86% | 0.91% | 0.93% | - |
| Sharpe | 1.12% | 0.96% | 0.59% | - |
| Sortino | 1.98% | 2.01% | 0.85% | - |
| Treynor | 0.10% | 0.08% | 0.06% | - |
| Tax Efficiency | 89.73% | 91.89% | 86.55% | - |
| Start Date | May 05, 2017 |
|---|---|
| Instrument Type | Mutual Fund (Wrap Program) |
| Share Class | Commission Based Advice |
| Legal Status | Trust |
| Sales Status | Open |
| Currency | CAD |
| Distribution Frequency | Annual |
| Assets ($mil) | $618 |
| FundServ Code | Load Code | Sales Status |
|---|---|---|
| MMF3182 |
The objective of the Fund is to achieve long-term capital appreciation. The Portfolio seeks to accomplish its objective by primarily investing in securities of Underlying Funds and/or ETFs. These Underlying Funds and/or ETFs generally invest in domestic and global equity securities and/or domestic and global fixed income securities. The fundamental investment objective of the Fund cannot be changed without the approval of investors who own securities in the Fund.
The portfolio sub-advisor employs a strategic asset allocation process and has the ability to make tactical calls depending on its view on market conditions at a point in time. The Portfolio primarily invests its assets in various Underlying Funds and/or ETFs, many of which are also managed by us. The Portfolio may also invest a portion of its assets in securities, guaranteed investment certificates, cash and short-term money market instruments.
| Portfolio Manager |
Manulife Investment Management Limited
|
|---|---|
| Sub-Advisor |
Manulife Investment Management (US) LLC
|
| Fund Manager |
Manulife Investment Management Limited |
|---|---|
| Custodian |
RBC Investor Services Trust (Canada) |
| Registrar |
Manulife Investment Management Limited |
| Distributor |
- |
| RSP Eligible | Yes |
|---|---|
| PAC Allowed | Yes |
| PAC Initial Investment | - |
| PAC Subsequent | - |
| SWP Allowed | Yes |
| SWP Min Balance | - |
| SWP Min Withdrawal | - |
| MER | 1.90% |
|---|---|
| Management Fee | - |
| Load | No Load |
| FE Max | - |
| DSC Max | - |
| Trailer Fee Max (FE) | - |
| Trailer Fee Max (DSC) | - |
| Trailer Fee Max (NL) | 0.00% |
| Trailer Fee Max (LL) | - |
Try Fund Library Premium
For Free with a 30 day trial!